Alimera Sciences P/E
Mi az Alimera Sciences P/E?
A P/E az Alimera Sciences Inc. - 184.33
Mi a P/E meghatározása?
Ár / nyereség arány a vállalat részvényárfolyamának aránya a társaság egy részvényre jutó nyereségével, amelyet tizenkét hónap alatt számítottak ki.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E a Health Care szektor a NASDAQ-on cégekben a Alimera Sciences -hoz képest
Mit csinál Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
p/e -hoz hasonló cégek Alimera Sciences
- Multi Commodity Exchange of India nak P/E 183.77 van
- Gabriel India nak P/E 183.83 van
- Century Textiles and Industries nak P/E 183.84 van
- PRA Inc nak P/E 183.91 van
- Gennex Laboratories nak P/E 184.10 van
- Tuscan nak P/E 184.26 van
- Alimera Sciences nak P/E 184.33 van
- Rocket Companies nak P/E 184.60 van
- Shiseido Co nak P/E 184.73 van
- RealPage nak P/E 184.83 van
- Parsons Corp nak P/E 186.55 van
- Crest Ventures nak P/E 186.61 van
- Anant Raj nak P/E 186.64 van